Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The market for these drugs is expected to grow.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Dutasteride may reduce insulin sensitivity and increase body fat.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

5-Alpha-Reductase Inhibitors can cause negative side effects.

Combination therapy is more effective for prostate volumes over 60 ml.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Long use of finasteride and dutasteride can cause long-term erection problems.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.